DETECTION OF HEPATITIS-C VIREMIA IN CAUCASIAN PATIENTS WITH HEPATOCELLULAR-CARCINOMA

被引:17
作者
GARSON, JA
WICKI, AN
RING, CJA
JOLLER, H
ZALA, G
SCHMID, M
BUEHLER, H
机构
[1] UNIV HOSP ZURICH,ANAWA LABS,CH-8091 ZURICH,SWITZERLAND
[2] UNIV HOSP ZURICH,STADTSPITAL WAID,DEPT MED,CH-8091 ZURICH,SWITZERLAND
[3] UNIV HOSP ZURICH,DEPT CLIN IMMUNOL,CH-8091 ZURICH,SWITZERLAND
关键词
HEPATITIS-C; VIREMIA; HEPATOCELLULAR CARCINOMA; POLYMERASE CHAIN REACTION;
D O I
10.1002/jmv.1890380215
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Potential risk factors for the development of hepatocellular carcinoma were analysed in 40 Caucasian patients with this malignancy. A higher proportion (14 of 40; 35%) had evidence of hepatitis C virus (HCV) infection than had evidence of either hepatitis B virus (HBV) carriage (17.5%) or alcohol abuse (30%). In all 14 patients whose sera were reactive by HCV ELISA (Ortho second generation test), the presence of antibodies to HCV were confirmed by recombinant immunoblot assay (Ortho RIBA-2). Furthermore, two independent laboratories detected HCV-RNA in 10 of the 14 (71%) anti-HCV positive sera. Two additional sera were shown to contain HCV-RNA when reanalysed by a modified PCR using oligonucleotide primers designed to amplify a shorter fragment of the 5' noncoding region of the genome. Seven of the anti-HCV positive patients also had evidence of prior HBV infection and 2 admitted to alcohol abuse. HCV infection was the only identifiable risk factor in 6 patients. These data confirm the association between HCV infection and hepatocellular carcinoma and suggest that persistent viral replication accompanies tumour development in the majority of patients whose serum contains anti-HCV.
引用
收藏
页码:152 / 156
页数:5
相关论文
共 21 条
[1]  
BEASLEY RP, 1981, LANCET, V2, P1129
[2]   EFFECT OF ALPHA-INTERFERON THERAPY ON HEPATITIS-C VIREMIA IN COMMUNITY-ACQUIRED CHRONIC NON-A-HEPATITIS, NON-B-HEPATITIS - A QUANTITATIVE POLYMERASE CHAIN-REACTION STUDY [J].
BRILLANTI, S ;
GARSON, JA ;
TUKE, PW ;
RING, C ;
BRIGGS, M ;
MASCI, C ;
MIGLIOLI, M ;
BARBARA, L ;
TEDDER, RS .
JOURNAL OF MEDICAL VIROLOGY, 1991, 34 (02) :136-141
[3]  
BRUIX J, 1989, LANCET, V2, P1004
[4]   HEPATITIS-C VIRUS - THE MAJOR CAUSATIVE AGENT OF VIRAL NON-A, NON-B HEPATITIS [J].
CHOO, QL ;
WEINER, AJ ;
OVERBY, LR ;
KUO, G ;
HOUGHTON, M ;
BRADLEY, DW .
BRITISH MEDICAL BULLETIN, 1990, 46 (02) :423-441
[5]  
COLOMBO M, 1989, LANCET, V2, P1006
[6]   HCV CONFIRMATORY TESTING OF BLOOD-DONORS [J].
FOLLETT, EAC ;
DOW, BC ;
MCOMISH, F ;
YAP, PL ;
HUGHES, W ;
MITCHELL, R ;
SIMMONDS, P .
LANCET, 1991, 338 (8773) :1024-1024
[7]   IMPROVEMENT OF HCV GENOME DETECTION WITH SHORT PCR PRODUCTS [J].
GARSON, JA ;
RING, CJA ;
TUKE, PW .
LANCET, 1991, 338 (8780) :1466-1467
[8]   ENHANCED DETECTION BY PCR OF HEPATITIS-C VIRUS-RNA [J].
GARSON, JA ;
RING, C ;
TUKE, P ;
TEDDER, RS .
LANCET, 1990, 336 (8719) :878-879
[9]   DEMONSTRATION OF VIREMIA PATTERNS IN HEMOPHILIACS TREATED WITH HEPATITIS-C-VIRUS-CONTAMINATED FACTOR-VIII CONCENTRATES [J].
GARSON, JA ;
TUKE, PW ;
MAKRIS, M ;
BRIGGS, M ;
MACHIN, SJ ;
PRESTON, FE ;
TEDDER, RS .
LANCET, 1990, 336 (8722) :1022-1025
[10]   DIFFERENTIATION BETWEEN SPECIFIC AND NONSPECIFIC HEPATITIS-C ANTIBODIES IN CHRONIC LIVER-DISEASE [J].
GRAY, JJ ;
WREGHITT, TG ;
FRIEND, PJ ;
WIGHT, DGD ;
SUNDARESAN, V ;
CALNE, RY .
LANCET, 1990, 335 (8689) :609-610